Figs (FIGS) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this health care apparel company would post a loss of $0.02 per share when it actually produced a loss of $0.01, delivering a surprise of 50%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Figs, which belongs to the ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________ FORM 10-K _________________________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Numb ...

FIGS Releases Fourth Quarter and Full Year 2024 Financial Results 2024 Results Exceed Expectations with Net Revenues Growth of 1.8% YoY, Net Income Margin of 0.5%, and Adjusted EBITDA Margin of 9.3% Increases Share Repurchase Authorization by $50 Million SANTA MONICA, Calif., February 27, 2025 — FIGS, Inc. (NYSE: FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2024 financial resul ...

In its upcoming report, Figs (FIGS) is predicted by Wall Street analysts to post quarterly earnings of $0.01 per share, reflecting a decline of 80% compared to the same period last year. Revenues are forecasted to be $139.27 million, representing a year-over-year decrease of 3.9%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company announce ...

Private equity buyers are seeing value in the scrubs retailer.Shares of Figs (FIGS -3.85%) jumped this week after the company reportedly received a buyout offer for around $1 billion. In this video, Travis Hoium shows why private equity buyers may be interested and what the stock could do now.*Stock prices used were end-of-day prices of Dec. 11, 2024. The video was published on Dec. 12, 2024. ...

Long-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on operational aspects, understanding the long-term earnings power of companies, the competitive dynamics of the industries where they participate, and buying companies that we would like to hold independently of how the price moves in the future. Most QC calls will be holds, and that is by design. Only a very sm ...

For the quarter ended September 2024, Figs (FIGS) reported revenue of $140.21 million, down 1.5% over the same period last year. EPS came in at -$0.01, compared to $0.03 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $144.11 million, representing a surprise of -2.71%. The company delivered an EPS surprise of +50.00%, with the consensus EPS estimate being -$0.02.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number: 001-40448 FIGS, Inc. (Exact Name of Registrant as Specified in its Charter) Dela ...

Thomas Barwick/DigitalVision via Getty Images FIGS (NYSE:FIGS) 2Q24 results were not spectacular, with the company posting moderate growth and improved guidance, but at the expense of lower margins. The company is spending more on product and marketing to drive the top line. My view on the company and the stock has not changed. FIGS has a good product, but its lack of cost management financed by a high gross margin makes it vulnerable to competition from below. The stock discounts a significant improvement ...

Financial Data and Key Metrics Changes - Net revenues increased by 4.4% to $144.2 million compared to Q2 last year, reflecting higher orders from existing customers despite a lower average order value (AOV) [24][25] - Adjusted EBITDA for Q2 was $12.9 million, with an adjusted EBITDA margin of 9%, down from 13.7% in Q2 of 2023 [25][26] - Gross margin for Q2 was 67.4%, compared to 69.5% in Q2 of 2023, primarily due to a shift in product category mix and reclassification of duty subsidies [24][25] Business Line Data and Key Metrics Changes - Non-scrubwear categories grew by 13%, reaching 18% of net revenues, indicating a successful expansion beyond core scrubwear [11][24] - The U.S. growth returned to positive territory, driven by improved repeat frequency trends, while international growth accelerated to 32% year-on-year [13][24] Market Data and Key Metrics Changes - International revenue growth accelerated to 32% from 29% in the first quarter of 2024, despite a negative impact of 12 percentage points from duty subsidies [13][24] - The company reported that branded search for FIGS is now equal to that for scrubs, indicating strong brand recognition [12] Company Strategy and Development Direction - The company is focusing on product innovation and broadening brand reach, particularly through its partnership with Team USA for the Olympics, which is seen as a key strategic driver [5][10] - The company aims to evolve into a lifestyle brand, with new product categories and collaborations expected to enhance long-term growth [11][20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the long-term growth opportunity, despite current macroeconomic uncertainties affecting consumer purchasing behavior [35][36] - The full-year revenue growth outlook has been raised to a range of flat to positive 2%, reflecting strong Q2 performance and visibility into the second half of the year [20][27] Other Important Information - The company has a strong balance sheet with over $268 million in cash and no debt, allowing for strategic investments and a $50 million share repurchase program [22][27] - A new Chief Financial Officer, Sarah Oughtred, has been appointed, bringing extensive experience from lululemon [18] Q&A Session Summary Question: Consumer engagement metrics and trends - Management noted positive trends in repeat frequency driven by product innovation and marketing, but highlighted ongoing uncertainty in the macro environment affecting overall purchasing levels [34][35] Question: Margin levels between core business and new innovations - Management indicated that new products currently have lower margins but expect them to improve as they scale, with core products benefiting from the success of new innovations [36][37] Question: Insights from the Olympic marketing campaign - The campaign has generated significant impressions and engagement, shaping future marketing strategies to focus on top-of-funnel brand building [40][41] Question: Future marketing opportunities and pricing strategy - The Olympic campaign is expected to open doors for future collaborations, and pricing for new products will be strategic to ensure accessibility while capitalizing on demand [46][47] Question: Trends in international markets - International growth was reported at 44%, with strong performance in established markets and significant opportunities in newer markets [56][57]